LOW SERUM-CHOLESTEROL AND SUICIDE

被引:408
作者
ENGELBERG, H [1 ]
机构
[1] CEDARS SINAI MED CTR, DEPT MED, LOS ANGELES, CA 90048 USA
关键词
D O I
10.1016/0140-6736(92)90609-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary prevention trials which have shown that the lowering of serum cholesterol concentrations in middle-aged subjects by diet, drugs, or both leads to a decrease in coronary heart disease have also reported an increase in deaths due to suicide or violence. There has been no adequate explanation for this association. I have reviewed the relevant published work and describe a physiological mechanism that might account for this curious finding. One of the functions of serotonin in the central nervous system is the suppression of harmful behavioural impulses. When mouse brain synaptosomal membrane cholesterol is increased there is a pronounced increase in the number of serotonin receptors. Low membrane cholesterol decreases the number of serotonin receptors. Since membrane cholesterol exchanges freely with cholesterol in the surrounding medium, a lowered serum cholesterol concentration may contribute to a decrease in brain serotonin, with poorer suppression of aggressive behaviour.
引用
收藏
页码:727 / 729
页数:3
相关论文
共 25 条
[1]  
ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193
[2]   VERTICAL DISPLACEMENT OF MEMBRANE PROTEINS MEDIATED BY CHANGES IN MICROVISCOSITY [J].
BOROCHOV, H ;
SHINITZKY, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (12) :4526-4530
[3]   INFLUENCE OF INCREASED MEMBRANE CHOLESTEROL ON MEMBRANE FLUIDITY AND CELL-FUNCTION IN HUMAN RED BLOOD-CELLS [J].
COOPER, RA .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, 8 (04) :413-430
[4]   LIPID FLUIDITY MARKEDLY MODULATES THE BINDING OF SEROTONIN TO MOUSE-BRAIN MEMBRANES [J].
HERON, DS ;
SHINITZKY, M ;
HERSHKOWITZ, M ;
SAMUEL, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (12) :7463-7467
[5]  
HERSHKOWITZ M, 1982, PROG BRAIN RES, V56, P419
[6]  
HORROBIN DF, 1990, BRIT MED J, V301, P554, DOI 10.1136/bmj.301.6751.554-b
[7]  
JENKINS CD, 1969, PSYCHOSOM MED, V31, P115
[8]  
JOHNSON DA, 1979, MOL PHARMACOL, V15, P739
[9]  
KAPLAN JR, 1990, PSYCHOSOM MED, V52, P226
[10]   LIPID-LOWERING DRUGS [J].
MCLOUGHLIN, I ;
CLARKE, P .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :275-276